drugset / Trial / NCT01056874

Effect Of Maraviroc On The Pharmacokinetics Of Digoxin

NCT01056874

Phase 1 Completed 12 enrolled ViiV Healthcare Pfizer · collab
RandomizedCrossoverOpen-labelTreatment

Summary

This is an open labelled study to estimate the effect of maraviroc on the pharmacokinetics of digoxin, a probe for p-glycoprotein.

Timeline

Start
2010-03
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified 0.25 mg Oral
Subject Maraviroc Other / unclassified 300 mg Oral